NIFEDIPINE ER (nifedipine)
CALCIUM CHANNEL BLOCKERS · HYPERTENSION ·+2
REMEDYREPACK, I
Drug class
Calcium Channel Blockers
Calcium channel blockers are a recognized class of cardiovascular medications that inhibit the transmembrane influx of calcium ions into cardiac muscle and vascular smooth muscle through voltage-gated L-type calcium channels. Read more about Calcium Channel Blockers
344 drugs in this class 144 manufacturers
Drugs in Calcium Channel Blockers
CARDAMYST (etripamil)
CALCIUM CHANNEL BLOCKERS · PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
MILESTONE PHARM
DILTIAZEM HCL
CALCIUM CHANNEL BLOCKERS · PREVENTION OF ANGINAL PAIN ASSOCIATED WITH VASOSPASTIC ANGINA ·+1
ALEMBIC PHARMAC
NICARDIPINE HCL
CALCIUM CHANNEL BLOCKERS · HYPERTENSION ·+1
AMICI PHARMA, I
VERAPAMIL HCL
CALCIUM CHANNEL BLOCKERS · PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA ·+2
REMEDYREPACK, I
NICARDIPINE HCL
CALCIUM CHANNEL BLOCKERS · HYPERTENSION
SAGENT PHARMACE
AMLODIPINE BESYLATE-BENAZEPRIL (amlodipine besylate/benazepril HCl)
ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS · HYPERTENSION
GSMS, INC.
DILTIAZEM 24HR ER (CD) (diltiazem HCl)
CALCIUM CHANNEL BLOCKERS · HYPERTENSION ·+1
REMEDYREPACK, I
SDAMLO (amlodipine besylate)
CALCIUM CHANNEL BLOCKERS · HYPERTENSION ·+2
PANGEA PHARMACE
Filter & compare in the drug finder →
Opens the drug finder with Calcium Channel Blockers preselected. Add indication or manufacturer filters there.
Calcium channel blockers are a recognized class of cardiovascular medications that inhibit the transmembrane influx of calcium ions into cardiac muscle and vascular smooth muscle through voltage-gated L-type calcium channels.
By decreasing intracellular calcium availability, they promote vascular smooth muscle relaxation and arterial vasodilation, while non-dihydropyridine subclasses also depress sinoatrial node automaticity and delay atrioventricular conduction.
Therapeutically, this pharmacologic class is widely indicated for the management of hypertension, chronic stable and vasospastic angina pectoris, and certain supraventricular arrhythmias.
-
fda.gov
Calcium channel blockers are a recognized class of cardiovascular medications that inhibit the transmembrane influx of calcium ions into cardiac muscle and vascular smooth muscle through voltage-gated L-type calcium channels By decreasing intracellular calcium availability, they promote vascular smooth muscle relaxation and arterial vasodilation, while non-dihydropyridine subclasses also depress sinoatrial node automaticity and delay atrioventricular conduction
-
nih.gov
Calcium channel blockers are a recognized class of cardiovascular medications that inhibit the transmembrane influx of calcium ions into cardiac muscle and vascular smooth muscle through voltage-gated L-type calcium channels By decreasing intracellular calcium availability, they promote vascular smooth muscle relaxation and arterial vasodilation, while non-dihydropyridine subclasses also depress sinoatrial node automaticity and delay atrioventricular conduction
-
fda.gov
By decreasing intracellular calcium availability, they promote vascular smooth muscle relaxation and arterial vasodilation, while non-dihydropyridine subclasses also depress sinoatrial node automaticity and delay atrioventricular conduction Therapeutically, this pharmacologic class is widely indicated for the management of hypertension, chronic stable and vasospastic angina pectoris, and certain supraventricular arrhythmias
-
fda.gov
Therapeutically, this pharmacologic class is widely indicated for the management of hypertension, chronic stable and vasospastic angina pectoris, and certain supraventricular arrhythmias
-
nih.gov
Therapeutically, this pharmacologic class is widely indicated for the management of hypertension, chronic stable and vasospastic angina pectoris, and certain supraventricular arrhythmias
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.